2019 Value and Innovation Report
Our 2019 Value and Innovation Report examines the different ways in which Celgene’s pursuit of innovation creates value for patients, the health system, the economy and society, and future innovation. First published in 2018, we issue this report on an annual basis to track our progress using our four value pillars.
Key Facts in Multiple Myeloma
Celgene innovation has played a key role in bringing forward significant advancements in outcomes for patients with multiple myeloma. The improvements in the understanding of the disease and patient outcomes are the result of considerable time and resources invested by Celgene over the years.
and healthcare policy opinion leaders.